BioSpace News Archive

Bloomage Biotech has been awarded the prestigious Fountain Awards at the Asia-Pacific international event, PCHi, held in Guangzhou from February 15th to 17th, 2023.

CÚRAM SFI Research Centre for Medical Devices researchers have published in Nature Communications a key study establishing a new pre-clinical model to develop clinically relevant treatments for heart attacks. This research resulted from an established collaboration of CÚRAM with European institutions

Catalyst OrthoScience Inc. has announced publication of a new study in the Journal of Shoulder and Elbow Surgery that shows positive clinical outcomes using the Catalyst™ CSR total shoulder system, compared to standard stemmed TSAs.

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated the use of noninvasive, continuous Masimo PVi®.

Virion Therapeutics, LLC presented data today of a genetically encoded checkpoint modifier-based immunotherapy, which enhances CD8+ T cell activation, in a fast-growing preclinical tumor model at the ESMO Target Anticancer Therapies Congress in Paris France.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced full results from the Phase 3 STELLAR trial, which evaluated sotatercept, Merck’s novel investigational activin signaling inhibitor biologic, in combination with stable background therapy for the treatment of adult patients with pulmonary arterial hypertension (PAH) (WHO Group 1).

Hamamatsu announced a multi-year distribution agreement with Siemens Healthineers.

Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held in Miami, Florida , on March 14-16, 2023.

ReSuture, Inc, (ReSuture) a dynamic early-stage business developing synthetic training models to expedite adoption of life-saving therapies and medical devices, today announced it has received a $996,413 Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF).

Pinehurst Surgical Clinic today announced successful completion of the first series of cases in the BalancedBack Total Joint Replacement pivotal clinical trial using the breakthrough 3Spine MOTUS device, an alternative to spinal fusion surgery.